AnalystsMatthew HewittMatthew Hewitt's Stock Forecasts
AnalystsMatthew Hewitt
Analyst Ranking
Top 45%
#2343 out of 5256 analysts
Average Return
+12.63%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Matthew Hewitt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Lifecore Biomedical IncLFCR | +73.36% | $4.58 | $7.94 | 2024-09-04 - 2025-09-04 | Buy |
Cryoport IncCYRX | +34.22% | $7.89 | $10.59 | 2026-03-29 - 2026-04-20 | Buy |
Lifecore Biomedical IncLFCR | +4.51% | $7.31 | $7.64 | 2024-11-21 - 2025-11-21 | Buy |
Apyx Medical CorpAPYX | +0.25% | $3.93 | $3.94 | 2026-03-10 - 2026-04-20 | Buy |
Matthew Hewitt Analyst Color
Get additional color on Matthew Hewitt's coverage of popular stocks
Matthew Hewitt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cryoport IncCYRX | 1 | Buy | $15.00 | +41.64% | Initiates Coverage On | 22 days ago |
Apyx Medical CorpAPYX | 1 | Buy | $6.00 | +52.28% | Maintains | a month ago |
Certara IncCERT | 1 | Buy | $16.00 | +158.48% | Initiates Coverage On | 7 months ago |
Lifecore Biomedical IncLFCR | 2 | Buy | $10.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.